LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Colorectal Screening

Colorectal Screening is the third most commonly diagnosed cancer among women in the United States with 90% of cases occurring after age 50 with a 4.5% of women chance of individuals over their lifetime developing colorectal cancer.1 Current guidelines emphasize routine screening beginning at age 45.2

American College of Obstetricians and Gynecologists recommends colorectal cancer screening3 for:

  • Women age 50 and above
  • Colorectal cancer or adenomatous polyps in first degree relative <60 years or in two or more first-degree relatives of any ages
  • Family history of familial adenomatous polyposis or hereditary nonpolyposis colon cancer
  • History of colorectal cancer, adenomatous polyps, inflammatory bowel disease, chronic ulcerative colitis or Crohn disease

Testing methods include the following:4

  • Colonoscopy every 10 years is preferred
  • Flexible sigmoidoscopy every 5 years
  • Double contract barium enema test every 5 years
  • Computed tomography every 5 years
  • Fecal occult blood test or fecal immunochemical test

For more information, please download the following brochures:

Colorectal Cancer Prevention, Detection, and Management   Colorectal Cancer Comprehensive Testing Services

LabCorp offers a wide range of colorectal screening options.


  1. American Cancer Society. Colorectal Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2014.
  2. American Cancer Society. American Cancer Society Guidelines for Colorectal Cancer Screening. Accessed June 5, 2018.
  3. American College of Obstetricians and Gynecologists. Well Women Recommendations. High-Risk Factors. Available at:
  4. American College of Obstetricians and Gynecologists. Annual Women’s Health Care. For Patients. Available at: